Abstract
Obtaining reasonable estimates for transmission rates from observed data is a challenge when using mathematical models to study the dynamics of “infectious” diseases, like Ebola. Most models assume the transmission rate of a contagion does not vary over time. However, these rates do vary during an epidemic due to environmental conditions, social behaviors, and public-health interventions deployed to control the disease. Therefore, obtaining time-dependent rates can aid in understanding the progression of disease through a population. We derive an analytical expression using a standard SIR-type mathematical model to compute time-dependent transmission rate estimates for an epidemic in terms of either incidence or prevalence type available data. We illustrate applicability of our method by applying data on various public health problems, including infectious diseases (Ebola, SARS, and Leishmaniasis) and social issues (obesity and alcohol drinking) to compute transmission rates over time. We show that transmission rate estimates can have a large variation over time, depending on the type of available data and other epidemiological parameters. Time-dependent estimation of transmission rates captures the dynamics of the problem and can be utilized to understand disease progression through population accurately. Alternatively, constant estimations may provide unacceptable results that could have major public health consequences.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval was required
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
anujmubayi{at}yahoo.com
abhishek.pandey{at}yale.edu
brasiccs23{at}uww.edu (C.B.); ghosha{at}uww.edu (A.G.)
anamikamubayi{at}yahoo.co.in
phool.ghosh{at}gmail.com
Data Availability
Data from public domain has been obtained
Abbreviations
- CDC
- Center for Disease Control
- MCMC
- Monte Carlo Markov Chains
- SIR
- Susceptible–Infectious–Recovered
- SARS
- Severe Acute Respiratory Syndrome
- USA
- United States of America
- US
- United States
- VL
- Visceral Leishmaniasis
